SCHEMBL10128535

SCHEMBL10128535

Cc1cc(Nc2nc(N[C@H]3CCCC[C@@H]3N)[nH]c(=O)c2C(N)=O)ccc1S(C)(=O)=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 17/20 0.64
FER P16591 3/20 0.46
ZAP70 P43403 1/20 0.44
MAPK1 P28482 4/20 0.43
MAPK3 P27361 3/20 0.43
KCNH2 Q12809 3/20 0.43
AURKB Q96GD4 3/20 0.43
GP6 Q9HCN6 1/20 0.43
CDC7 O00311 1/20 0.43
PLK4 O00444 1/20 0.43
CHEK1 O14757 1/20 0.43
PDPK1 O15530 1/20 0.43
DAPK3 O43293 1/20 0.43
DYRK3 O43781 1/20 0.43
JAK2 O60674 1/20 0.43
ROCK2 O75116 1/20 0.43
RPS6KA5 O75582 1/20 0.43
PRKD3 O94806 1/20 0.43
MAP4K4 O95819 1/20 0.43
PAK4 O96013 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10128663 0.91 SYK (0.61) SYKFERZAP70MAPK1MAPK3
SCHEMBL10128530 0.90 SYK (0.61) SYKFERZAP70
SCHEMBL10128227 0.87 SYK (0.67) SYKZAP70MAPK1MAPK3KCNH2
SCHEMBL10128224 0.85 SYK (0.65) SYKFERZAP70MAPK1MAPK3
SCHEMBL10128698 0.84 SYK (0.64) SYKFERMAPK1MAPK3KCNH2
SCHEMBL2715387 0.83 SYK (0.79) SYKFERZAP70MAPK1MAPK3
SCHEMBL10128405 0.83 SYK (0.59) SYKFERZAP70KCNH2
SCHEMBL10156814 0.83 SYK (0.64) SYKFERMAPK1MAPK3KCNH2
SCHEMBL10128677 0.82 SYK (0.61) SYKFERJAK2
SCHEMBL16303174 0.81 SYK (0.65) SYKZAP70LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 SYK 2200/4885FER 160/4885ZAP70 2470/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.